Asset Details
Do you wish to reserve the book?
Engineered immunogen binding to alum adjuvant enhances humoral immunity
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Engineered immunogen binding to alum adjuvant enhances humoral immunity
Do you wish to request the book?
Engineered immunogen binding to alum adjuvant enhances humoral immunity
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Engineered immunogen binding to alum adjuvant enhances humoral immunity
2020
Overview
Adjuvants are central to the efficacy of subunit vaccines. Aluminum hydroxide (alum) is the most commonly used vaccine adjuvant, yet its adjuvanticity is often weak and mechanisms of triggering antibody responses remain poorly understood. We demonstrate that site-specific modification of immunogens with short peptides composed of repeating phosphoserine (pSer) residues enhances binding to alum and prolongs immunogen bioavailability. The pSer-modified immunogens formulated in alum elicited greatly increased germinal center, antibody, neutralizing antibody, memory and long-lived plasma cell responses compared to conventional alum-adsorbed immunogens. Mechanistically, pSer-immunogen:alum complexes form nanoparticles that traffic to lymph nodes and trigger B cell activation through multivalent and oriented antigen display. Direct uptake of antigen-decorated alum particles by B cells upregulated antigen processing and presentation pathways, further enhancing B cell activation. These data provide insights into mechanisms of action of alum and introduce a readily translatable approach to significantly improve humoral immunity to subunit vaccines using a clinical adjuvant.
Alum coupled to protein immunogens via site-specific phosphoserine-containing linkers enhances long-lived B cell responses and can selectively direct antibodies toward protective neutralizing epitopes.
Publisher
Nature Publishing Group US,Nature Publishing Group
Subject
/ Adjuvants, Immunologic - pharmacology
/ Alum
/ Aluminum
/ Aluminum Hydroxide - pharmacology
/ Animals
/ Antigen Presentation - drug effects
/ Antigens
/ B-Lymphocytes - drug effects
/ Binding
/ Biomedical and Life Sciences
/ Epitopes
/ Immunity
/ Immunity, Humoral - drug effects
/ Immunologic Memory - drug effects
/ Lymphocyte Activation - drug effects
/ Peptides
/ Testing
/ Vaccines
